User profiles for Emily R. Whelan
 | Emily R WhelanPredoctoral Student at Mayo Clinic Verified email at mayo.edu Cited by 2126 |
Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients
…, DO Hodge, JRA Shepherd, RF Rea, ER Whelan… - Mayo Clinic …, 2020 - Elsevier
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients
…, JRA Shepherd, RF Rea, ER Whelan… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19
…, DO Hodge, V Herasevich, ER Whelan… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …
under the presumption that such plasma contains potentially therapeutic …
[HTML][HTML] Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study
…, L Katz, V Herasevich, DA Waxman, ER Whelan… - PLoS …, 2021 - journals.plos.org
Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
[HTML][HTML] Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
…, RF Rea, V Herasevich, ER Whelan… - Nature …, 2021 - nature.com
Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
[HTML][HTML] Rates among hospitalized patients with COVID-19 treated with Convalescent plasma: A systematic review and meta-analysis
…, N van Helmond, MNP Vogt, ER Whelan… - … : Innovations, Quality & …, 2023 - Elsevier
Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19. …
mortality and the differences between subgroups in hospitalized patients with COVID-19. …
Reconstituted extracellular vesicles from human platelets decrease viral myocarditis in mice
…, V Xu, I Chekuri, P Giresi, DN Di Florio, ER Whelan… - Small, 2023 - Wiley Online Library
Patients with viral myocarditis are at risk of sudden death and may progress to dilated
cardiomyopathy (DCM). Currently, no disease‐specific therapies exist to treat viral myocarditis. …
cardiomyopathy (DCM). Currently, no disease‐specific therapies exist to treat viral myocarditis. …
[HTML][HTML] Trpc6 promotes doxorubicin-induced cardiomyopathy in male mice with pleiotropic differences between males and females
…, KA Bruno, DN Di Florio, ER Whelan… - Frontiers in …, 2022 - frontiersin.org
Background: Doxorubicin is a widely used and effective chemotherapy, but the major limiting
side effect is cardiomyopathy which in some patients leads to congestive heart failure. …
side effect is cardiomyopathy which in some patients leads to congestive heart failure. …
[HTML][HTML] Upregulation of endothelin-1 may predict chemotherapy-induced cardiotoxicity in women with breast cancer
…, DN Di Florio, BH Edenfield, ER Whelan… - Journal of clinical …, 2022 - mdpi.com
As survival in breast cancer patients from newer therapies increases, concerns for
chemotherapy-induced cardiotoxicity (CIC) have offset some of these benefits, manifesting as a …
chemotherapy-induced cardiotoxicity (CIC) have offset some of these benefits, manifesting as a …
[HTML][HTML] Sex-specific effects of plastic caging in murine viral myocarditis
…, DN Di Florio, BH Edenfield, ER Whelan… - International journal of …, 2021 - mdpi.com
Background: Myocarditis is an inflammatory heart disease caused by viral infections that can
lead to heart failure, and occurs more often in men than women. Since animal studies have …
lead to heart failure, and occurs more often in men than women. Since animal studies have …